Document is current
Any future updates will be listed below
-
Authors
Li, Chenghui
Peng, Cheng
DelNero, Peter
Laryea, Jonathan
Ramirez Aguilar, Daniela
Koru, Güneş
Park, Yong-Moon Mark
Saini, Mahima
Schootman, Mario
-
Funding
Funding for this research was provided by:
American Cancer Society (RSGI‐23‐1039245‐01‐HOPS)
National Center for Advancing Translational Sciences (UL1 TR003107, UL1 TR003107-02S2)
- License Information
-
More Information
Article History
Received: 1 June 2024
Accepted: 8 September 2024
First Online: 22 September 2024
Declarations
:
: Chenghui Li received research support for unrelated projects sponsored by University of Utah/AstraZeneca. Dr. Koru owns Maryland Health Information Technology LLC and Maryland Data Science and Engineering LLC. Other authors have no conflicts of interest to declare.
: This is an observational study. The University of Arkansas for Medical Sciences Internal Review Board has determined that this is not a human subject study (IRB #27580).
